Stemcell United

Stemcell United Cash Conversion

The Cash Conversion Rate (OCF/Net Income) of Stemcell United (SCU.AX) as of Nov 16, 2026 is 91.76 %. In the previous year, Cash Conversion Rate (OCF/Net Income) was 38.24 % — a change of 139.97% (higher).

Cash Conversion

91.76 %

YoY

139.97%

Last updated:

Cash Conversion Rate (OCF/Net Income) of Stemcell United is 2022 91.76 % . Cash Conversion Rate (OCF/Net Income) of Stemcell United was 2021 38.24 % . It decreases by 139.97% higher compared to the previous year.

The Stemcell United Cash Conversion history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Cash Conversion
Date
Cash Conversion
Jan 1, 2015
-0.82 AUD
Jan 1, 2016
2.71 AUD
Jan 1, 2017
10.14 AUD
Jan 1, 2018
46.53 AUD
Jan 1, 2019
25.08 AUD
Jan 1, 2020
76.83 AUD
Jan 1, 2021
38.24 AUD
Jan 1, 2022
91.76 AUD
The Stemcell United Cash Conversion history
YEARCash ConversionYoY
91.76 %+139.97%
38.24 %-50.22%
76.83 %+206.34%
25.08 %-46.10%
46.53 %+359.04%
10.14 %+274.26%
2.71 %-431.58%
-0.82 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Stemcell United Stock analysis

What does Stemcell United do? Stemcell United Ltd is an internationally operating company that is active in the field of stem cell research and therapy. It was founded in 2005 by British entrepreneur and scientist Dr. Samantha Phillips, who previously worked for the renowned Roslin Institute for Animal Genetics. The business model of Stemcell United is based on the development and distribution of innovative therapies that are based on the use of stem cells as a foundation. The company primarily relies on close collaboration with leading research institutions and clinics worldwide to stay up to date with the latest research and develop products and services that are based on current knowledge and meet the highest quality standards. The various divisions of Stemcell United include the development and production of stem cell-based therapies for diseases such as cancer, heart attack, dementia, and stroke. Additionally, the company also offers support and consultation in the field of clinical trials as well as training for doctors and researchers to improve and optimize the use of stem cell therapies. Another important area of Stemcell United's business activities is the production and marketing of stem cells for research purposes. Both embryonic and adult stem cells are produced and provided to advance research in this field and gain new insights. The products offered by Stemcell United mainly include stem cell preparations for wound healing and tissue regeneration, as well as specialized cell cultures for research in the field of stem cell therapy. These products are sold to clinics, research institutions, and end consumers and are available in many countries worldwide. In recent years, Stemcell United has become one of the leading companies in the field of stem cell research and therapy and enjoys a high reputation in the industry. The company primarily relies on close collaboration with other top companies in the industry and a strong connection to research and development in this field. Overall, Stemcell United is an innovative and dynamic company that sets standards in the field of stem cell research and therapy worldwide and constantly seeks new ways to utilize the possibilities of stem cell therapy for the health and well-being of humans and animals. Stemcell United is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Stemcell United stock

Cash Conversion Rate (OCF/Net Income) of Stemcell United is 91.76 % in 2022.

Cash Conversion Rate (OCF/Net Income) of Stemcell United changed from 38.24 % to 91.76 %, representing a 139.97% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Cash Conversion Rate (OCF/Net Income) Stemcell United since 2006 – with annual values, charts, and detailed analysis.

Cash conversion measures how effectively net income converts to operating cash flow. Ratios above 100% indicate high-quality, cash-backed earnings.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Cash Conversion Rate (OCF/Net Income)'s Stemcell United with sector peers and the industry average to assess whether it is attractive.

To evaluate Cash Conversion Rate (OCF/Net Income)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Cash Conversion Rate (OCF/Net Income).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Stemcell United

All Key Metrics — Stemcell United